Survival outcomes in prostate cancer patients with a prior cancer.

Zang, Yan; Qi, Feng; Cheng, Yifei; Xia, Tian; Xiao, Rongrong; Li, Xiao; Yang, Ningli

Zang, Yan; Qi, Feng; Cheng, Yifei; Xia, Tian; Xiao, Rongrong; Li, Xiao; Yang, Ningli.

Afiliação

Zang Y; Department of Bariatric and Metabolic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qi F; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Cheng Y; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xia T; Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Xiao R; Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Li X; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Yang N; Department of Bariatric and Metabolic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Transl Androl Urol ; 10(2): 741-753, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33718076

Palavras-chave

Prostate cancer (PCa); Surveillance, Epidemiology, and End Results (SEER); prior cancer; prognostic factor; survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Androl Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google